Arun Swaminathan

Arun Swaminathan has extensive experience in the pharmaceutical and biotechnology industry. Arun is currently serving as the Chief Business Officer at Coya Therapeutics, Inc. Since 2023. Prior to that, they worked at Actinium Pharmaceuticals, Inc. as the Chief Business and Commercial Officer from 2021 to 2023. From 2018 to 2021, Arun held the position of Chief Business Officer & Senior Vice President at ALTEOGEN Inc. Arun also co-founded and served as the CEO of Lynkogen Inc. from 2016 to 2020. Arun has previously worked at Bristol-Myers Squibb in various roles, including Worldwide Brand Director and Senior Manager in Global Marketing. Arun started their career at West Pharmaceutical Services. Overall, Arun has had a diverse range of roles in business development, marketing, and leadership across different organizations.

Arun Swaminathan attended The Wharton School from 2003 to 2004, where they studied Marketing Management. Additionally, they pursued a Ph.D. in Pharmaceutical Sciences at the University of Pittsburgh, although the specific start and end years for this degree program are not mentioned.